XBI vs. PBPH
XBI (SPDR S&P Biotech ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - XBI tracks the S&P Biotechnology Select Industry Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. A 0.63 correlation means they provide meaningful diversification when combined. XBI charges 0.35%/yr vs 0.13%/yr for PBPH.
Performance
XBI vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBI achieves a 9.42% return, which is significantly higher than PBPH's 1.75% return.
XBI
- 1D
- 2.77%
- 1M
- -0.28%
- YTD
- 9.42%
- 6M
- 8.61%
- 1Y
- 62.35%
- 3Y*
- 15.65%
- 5Y*
- 1.14%
- 10Y*
- 8.53%
PBPH
- 1D
- 2.92%
- 1M
- 2.45%
- YTD
- 1.75%
- 6M
- 3.89%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XBI vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
XBI SPDR S&P Biotech ETF | 9.42% | 0.79% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 1.75% | 0.76% |
Correlation
The correlation between XBI and PBPH is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.63 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBI vs. PBPH — Risk / Return Rank
XBI
PBPH
XBI vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XBI | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.40 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 6.45 | — | — |
| Martin ratioReturn relative to average drawdown | 19.53 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XBI | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.45 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.04 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.27 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.29 | +0.07 |
Drawdowns
XBI vs. PBPH - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for XBI and PBPH.
Loading charts...
Drawdown Indicators
| XBI | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.89% | -11.10% | -52.79% |
Max Drawdown (1Y)Largest decline over 1 year | -9.72% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -32.99% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -54.71% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -63.89% | — | — |
Current DrawdownCurrent decline from peak | -22.89% | -6.03% | -16.86% |
Average DrawdownAverage peak-to-trough decline | -20.93% | -4.25% | -16.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.20% | — | — |
Volatility
XBI vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| XBI | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.69% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 20.31% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 25.60% | 17.20% | +8.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.20% | 17.20% | +15.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.00% | 17.20% | +14.80% |
XBI vs. PBPH - Expense Ratio Comparison
XBI has a 0.35% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
XBI vs. PBPH - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.33%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.33% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
XBI and PBPH have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.35% for XBI.
XBI has the higher dividend yield at 0.33%, compared with 0.09% for PBPH.
XBI tracks S&P Biotechnology Select Industry Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: State Street and Portfolio Building Block. Their fees differ too: 0.35% for XBI and 0.13% for PBPH.
Find the right allocation for XBI and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer